A self-reported clinical trial investigates the efficacy of 1072 nm light as an anti-ageing agent

J Cosmet Laser Ther. 2007 Dec;9(4):226-30. doi: 10.1080/14764170701400085.

Abstract

Background: Previous laboratory research has shown that human lymphocytes pre-irradiated with 1072 nm light are afforded some protection against subsequent ultraviolet light toxicity.

Objective: To investigate the possibility that 1072 nm light can prevent or reverse skin ageing which itself is known to be accelerated by ultraviolet light.

Methods: A randomized, prospective, double-blind, placebo-controlled, self-reporting study was performed to assess the effect of one daily treatment episode for a period of between 6 and 8 weeks on wrinkles and fine lines around the eyes as well as the appearance of bags under the eyes.

Results: Between 52% and 57% of volunteers were able to accurately identify an improvement in the fine lines and wrinkles of the treated areas of skin. Fewer volunteers, between 37% and 46%, observed an improvement in the bags under the treated eye or eyes, albeit with an emphatic statistical significance.

Conclusion: Regular application of a non-thermal quantity of 1072nm light around the eyes demonstrated efficacy as an anti-ageing agent.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Double-Blind Method
  • Female
  • Humans
  • Low-Level Light Therapy / methods*
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Phototherapy / methods*
  • Prospective Studies
  • Self Administration
  • Skin / radiation effects
  • Skin Aging / pathology
  • Skin Aging / radiation effects*
  • Treatment Outcome